SNDX - Syndax Pharmaceuticals Inc
IEX Last Trade
12.74
-0.010 -0.078%
Share volume: 67,664
Last Updated: Fri 27 Dec 2024 08:29:55 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$12.75
-0.01
-0.08%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
| Report Date | 2022-05-09 | 2022-08-08 | 2022-11-03 | |
| Cash flow financing | 557.000 K | 21.720 M | -13.525 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | -41.931 M | -40.306 M | -28.544 M | |
| Net income | -37.169 M | -37.572 M | -35.403 M | |
| Depreciation | 11.000 K | 11.000 K | 8.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 8.182 M | -49.948 M | -6.793 M | |
| Net Borrowings | -399.894 M | -371.956 M | -357.498 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | 410.909 M | 376.678 M | 350.708 M |